Alnylam Pharmaceuticals Company Contacts

Alnylam Pharmaceuticals

http://www.alnylam.com
To those who say “impossible, impractical, unrealistic,” we say: “CHALLENGE ACCEPTED.” Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring RNAi-based medicines to market. We are developing RNAi (RNA interference) as an innovative, entirely new... Read More
Contacts

Country

United States

City

Cambridge

Headquarters

Cambridge, Massachusetts

Profile

Founded

2002

Industry

Biotechnology Research

Size

1001 - 5000

Specialties

Biotech, Pharmaceuticals, Biopharma, Drug Development, Rare Diseases, RNAi

Funding

Total Rounds

8

Last Round

Mon Sep 12 2022

Last Round Series

Post IPO debt

Last Round Raised

$ 900,000,000